Green infrastructure and its catchment-scale effects: an emerging science

Urbanizing environments alter the hydrological cycle by redirecting stream networks for stormwater and wastewater transmission and increasing impermeable surfaces. These changes thereby accelerate the runoff of water and its constituents following precipitation events, alter evapotranspiration processes, and indirectly modify surface precipitation patterns. 

Green infrastructure, or low-impact development (LID), can be used as a standalone practice or in concert with gray infrastructure (traditional stormwater management approaches) for cost-efficient, decentralized stormwater management.

The growth in LID over the past several decades has resulted in a concomitant increase in research evaluating LID efficiency and effectiveness, but mostly at localized scales. There is a clear research need to quantify how LID practices affect water quantity (i.e., runoff and discharge) and quality at the scale of catchments.

BC-7013
HY-113640 1 mg
EUR 2077.95
Description: BC-7013 is a novel semi-synthetic pleuromutilin derivative. BC-7013 has excellent activity against Gram-positive pathogenic bacteria. BC-7013 exhibits potent antibacterial properties against both Staphylococcus, Streptococcus and penicillin-resistant Streptococcus pneumoniae. BC-7013 has activity against Gram-positive pathogenic bacteria, BC-7013 is useful in the research of acute bacterial skin and skin structure infection (ABSSSI)[1].

BC-05
HY-149514 Get quote Ask for price
Description: BC-05 is an orally active and potent inhibitor of CD13 and proteasome. BC-05 has an IC50 value of 0.13 μM for human CD13 and an IC50 value of 1.39 μM for the 20S proteasome. BC-05 can be used in multiple myeloma research[1].

BC-​1258
HY-129087 10 mg
EUR 346.33
Description: BC-1258, an F-box/LRR-repeat protein 2 (FBXL2) activator, can stabilize and upregulate FBXL2 levels. BC-1258 induces apoptosis of tumorigenic cells, and profoundly inhibits tumor formation in mice[1].

BC-1215
HY-117937 10mM/1mL
EUR 64.94
Description: BC-1215 is a F-box protein 3 (Fbxo3) inhibitor. BC-1215 works by antagonizing of Fbxo3 on TRAF cytokine signaling and exhibits a low IC50 in vitro. BC-1215 can be used for the research of inflammation[1].

BC-23
HY-119288 10 mg
EUR 259.74
Description: BC-23 (NSC 45382) is a proteasome inhibitor. BC-23 exhibits good inhibition of CT-L activity of the proteasome and is selective for malignant over normal cells[1][2].

BC-1471
HY-122883 10 mg
EUR 1623.4
Description: BC-1471 is a STAM-binding protein (STAMBP) deubiquitinase inhibitor. BC-1471 inhibits NALP7 (NACHT, LRR and PYD domains-containing protein 7) inflammasome activity[1].

BC-1215
MBS3602103-10mg 10mg
EUR 530

BC-1215
MBS3602103-25mg 25mg
EUR 845

BC-1215
MBS3602103-5mg 5mg
EUR 400

BC-1215
MBS3602103-5x25mg 5x25mg
EUR 3470

BC-1215
MBS3843069-100mg 100mg
EUR 870

BC-1215
MBS3843069-10mg 10mg
EUR 190

BC-1215
MBS3843069-50mg 50mg
EUR 520

BC-1215
MBS3843069-5mg 5mg
EUR 145

BC-1215
MBS3843069-5x100mg 5x100mg
EUR 3895

BC-1382
MBS5759350-10mg 10mg
EUR 470

BC-1382
MBS5759350-1mg 1mg
EUR 210

BC-1382
MBS5759350-25mg 25mg
EUR 780

BC-1382
MBS5759350-5mg 5mg
EUR 335

BC-1382
MBS5759350-5x25mg 5x25mg
EUR 3365

BC-1215
MBS5752167-100mg 100mg
EUR 615

BC-1215
MBS5752167-10mg 10mg
EUR 180

BC-1215
MBS5752167-25mg 25mg
EUR 260

BC-1215
MBS5752167-50mg 50mg
EUR 385

BC-1215
MBS5752167-5mg 5mg
EUR 150

BC-1471
MBS5764950-10mg 10mg
EUR 470

BC-1471
MBS5764950-1mg 1mg
EUR 210

BC-1471
MBS5764950-25mg 25mg
EUR 780

BC-1471
MBS5764950-50mg 50mg
EUR 1130

BC-1471
MBS5764950-5mg 5mg
EUR 335

BC-1258
MBS5765092-10mg 10mg
EUR 470

BC-1258
MBS5765092-1mg 1mg
EUR 210

BC-1258
MBS5765092-25mg 25mg
EUR 780

BC-1258
MBS5765092-2mg 2mg
EUR 255

BC-1258
MBS5765092-5mg 5mg
EUR 330

BC 197
MBS5774875-5mg 5(mg
EUR 915

BC 197
MBS5774875-5x5mg 5x5(mg
EUR 3970

BC-23
MBS5776481-5mg 5(mg
EUR 915

BC-23
MBS5776481-5x5mg 5x5(mg
EUR 3970

BC-7013
MBS5776482-5mg 5(mg
EUR 915

BC-7013
MBS5776482-5x5mg 5x5(mg
EUR 3970

BC-1471
T8553-10mg 10mg Ask for price
Description: BC-1471

BC-1471
T8553-1g 1g Ask for price
Description: BC-1471

BC-1471
T8553-1mg 1mg Ask for price
Description: BC-1471

BC-1471
T8553-50mg 50mg Ask for price
Description: BC-1471

BC-1471
T8553-5mg 5mg Ask for price
Description: BC-1471

BC-23
T26754-10mg 10mg Ask for price
Description: BC-23

BC-23
T26754-1g 1g Ask for price
Description: BC-23

BC-23
T26754-1mg 1mg Ask for price
Description: BC-23

BC-23
T26754-50mg 50mg Ask for price
Description: BC-23

BC-23
T26754-5mg 5mg Ask for price
Description: BC-23

BC-7013
T26755-10mg 10mg Ask for price
Description: BC-7013

BC-7013
T26755-1g 1g Ask for price
Description: BC-7013

BC-7013
T26755-1mg 1mg Ask for price
Description: BC-7013

BC-7013
T26755-50mg 50mg Ask for price
Description: BC-7013

BC-7013
T26755-5mg 5mg Ask for price
Description: BC-7013

BC 197
T25139-10mg 10mg Ask for price
Description: BC 197

BC 197
T25139-1g 1g Ask for price
Description: BC 197

BC 197
T25139-1mg 1mg Ask for price
Description: BC 197

BC 197
T25139-50mg 50mg Ask for price
Description: BC 197

BC 197
T25139-5mg 5mg Ask for price
Description: BC 197

BC-1215
T5821-10mg 10mg Ask for price
Description: BC-1215

BC-1215
T5821-1g 1g Ask for price
Description: BC-1215

BC-1215
T5821-1mg 1mg Ask for price
Description: BC-1215

BC-1215
T5821-50mg 50mg Ask for price
Description: BC-1215

BC-1215
T5821-5mg 5mg Ask for price
Description: BC-1215

BC-​1258
T8956-10mg 10mg Ask for price
Description: BC-​1258

BC-​1258
T8956-1g 1g Ask for price
Description: BC-​1258

BC-​1258
T8956-1mg 1mg Ask for price
Description: BC-​1258

BC-​1258
T8956-50mg 50mg Ask for price
Description: BC-​1258

BC-​1258
T8956-5mg 5mg Ask for price
Description: BC-​1258

BC-1382
T8564-10mg 10mg Ask for price
Description: BC-1382

BC-1382
T8564-1g 1g Ask for price
Description: BC-1382

BC-1382
T8564-1mg 1mg Ask for price
Description: BC-1382

BC-1382
T8564-50mg 50mg Ask for price
Description: BC-1382

BC-1382
T8564-5mg 5mg Ask for price
Description: BC-1382

BC-1471
TRC-B358215-250MG 250 mg Ask for price

BC-1382
TRC-B129353-50MG 50 mg Ask for price

BC-1382
TRC-B129353-10MG 10 mg Ask for price

BC-1382
TRC-B129353-100MG 100 mg Ask for price

BC 11 hydrobromide
A4444-10 10 mg
EUR 414.4
Description: Proteases|Urokinase

BC 11 hydrobromide
A4444-50 50 mg
EUR 1184.8
Description: Proteases|Urokinase

BC-11 hydrobromide
565139 1.0mg
EUR 230

BC-DXI-843
593189 10.0mg Ask for price

BC-LI-0186
461993 25.0mg
EUR 450

9-Me-BC
465405 1.0mg
EUR 220

BC Succinimidyl Ester
12565-1mg 1 mg
EUR 211
Description: CLIP-tag is a modified version of SNAP-tag.

BC 11 Hydrobromide
B129348 100mg
EUR 837
Description: 443776-49-6

BC 11-38
B7673-10 10 mg
EUR 120
Description: Metabolism|PDE

BC 11-38
B7673-25 25 mg
EUR 280
Description: Metabolism|PDE

BC 11-38
B7673-5 5 mg
EUR 141.6
Description: BC 11-38 is a selective inhibitor of PDE11 with an IC50 value of 0.28 ?M [1]. PDE11 is a PDE family. In humans the PDE11A gene encodes four isoforms hydrolyzing both cAMP and cGMP.

BC 11-38
B7673-50 50mg
EUR 943
Description: Selective PDE11 inhibitor

BC-11-38
20-abx076649
  • Ask for price
  • Ask for price
  • 10 mg
  • 50 mg

BC-11-38
abx076649-5ml 5 ml
EUR 118.75

BC-LI-0186
HY-136265 10 mg
EUR 562.78
Description: BC-LI-0186 is a potent and selective inhibitor of Leucyl-tRNA synthetase (LRS; LeuRS) and Ras-related GTP-binding protein D (RagD) interaction (IC50=46.11 nM). BC-LI-0186 competitively binds to the RagD interacting site of LRS (Kd=42.1 nM) and has on effects on LRS-Vps34, LRS-EPRS, RagB-RagD association, mTORC1 complex formation or the activities of 12 kinases. BC-LI-0186 can effectively suppress the activity of cancer-associated MTOR mutants and the growth of rapamycin-resistant cancer cells. BC-LI-0186 is a promising agent for lung cancer research[1][2].

BC-DXI-843
HY-136431 1 mg
EUR 573.6
Description: BC-DXI-843 is a potent and specific AIMP2-DX2 inhibitor with an IC50 of 0.92 μM, more than 100-fold selectivity over AIMP2 (IC50 >100 μM) in a luciferase assay. BC-DXI-843 acts as a promising lead targeting AIMP2-DX2 in lung cancer[1].

BC-11 (hydrobromide)
HY-108447 5 mg
EUR 211.04
Description: BC-11 hydrobromide is a selective TMPRSS2 inhibitor (TMPRSS2 is a key host cellular factor for viral entry and SARS-CoV-2 pathogenesis), and a selective urokinase (uPA) inhibitor (IC50=8.2 μM). BC-11 hydrobromide is cytotoxic to triple-negative MDA-MB231 breast cancer cells. BC-11 hydrobromide is used in research on viral infections and cancer[1][2][3].

SH-BC-893
HY-124758 1 mg
EUR 1623.4
Description: SH-BC-893 is an orally active anti-neoplastic sphingolipid analog. SH-BC-893 also protects from ceramide-induced mitochondrial dysfunction and corrects diet-induced obesity. SH-BC-893 can be used for the research of cancer and obesity[1][2].

BC 11 hydrobromide
MBS3841018-10mg 10mg
EUR 210

BC 11 hydrobromide
MBS3841018-50mg 50mg
EUR 615

BC 11 hydrobromide
MBS3841018-5x50mg 5x50mg
EUR 2755

BC-DXI-843
MBS5759260-10mg 10mg
EUR 225

BC-DXI-843
MBS5759260-25mg 25mg
EUR 320

BC-DXI-843
MBS5759260-2mg 2mg
EUR 155

BC-DXI-843
MBS5759260-50mg 50mg
EUR 450

BC-DXI-843
MBS5759260-5mg 5mg
EUR 180

BC 11 hydrobromide
MBS5757094-50mg 50mg
EUR 1205

BC 11 hydrobromide
MBS5757094-5x50mg 5x50mg
EUR 5270

BC-LI-0186
MBS5786394-10mg 10(mg
EUR 210

BC-LI-0186
MBS5786394-2mg 2(mg
EUR 160

BC-LI-0186
MBS5786394-5mg 5(mg
EUR 170

BC 11-38
MBS5773201-10mg 10mg
EUR 275

BC 11-38
MBS5773201-1mg 1mg
EUR 160

BC 11-38
MBS5773201-5mg 5mg
EUR 215

BC-11-38
MBS808077-10mg 10mg
EUR 275

BC-11-38
MBS808077-50mg 50mg
EUR 795

BC-11-38
MBS808077-5x10mg 5x10mg
EUR 990

BC-11-38
MBS808077-5x50mg 5x50mg
EUR 3300

BC-DXI-843
T8466-10mg 10mg Ask for price
Description: BC-DXI-843

BC-DXI-843
T8466-1g 1g Ask for price
Description: BC-DXI-843

BC-DXI-843
T8466-1mg 1mg Ask for price
Description: BC-DXI-843

BC-DXI-843
T8466-50mg 50mg Ask for price
Description: BC-DXI-843

BC-DXI-843
T8466-5mg 5mg Ask for price
Description: BC-DXI-843

BC 11-38
T21865-10mg 10mg Ask for price
Description: BC 11-38

BC 11-38
T21865-1g 1g Ask for price
Description: BC 11-38

BC 11-38
T21865-1mg 1mg Ask for price
Description: BC 11-38

BC 11-38
T21865-50mg 50mg Ask for price
Description: BC 11-38

BC 11-38
T21865-5mg 5mg Ask for price
Description: BC 11-38

BC 11 hydrobromide
T22600-10mg 10mg Ask for price
Description: BC 11 hydrobromide

BC 11 hydrobromide
T22600-1g 1g Ask for price
Description: BC 11 hydrobromide

BC 11 hydrobromide
T22600-1mg 1mg Ask for price
Description: BC 11 hydrobromide

BC 11 hydrobromide
T22600-50mg 50mg Ask for price
Description: BC 11 hydrobromide

BC 11 hydrobromide
T22600-5mg 5mg Ask for price
Description: BC 11 hydrobromide

BC-11-38
SIH-373-10MG 10 mg
EUR 124.8

BC-11-38
SIH-373-50MG 50 mg
EUR 553.6

BC-LI-0186
T9533-10mg 10mg Ask for price
Description: BC-LI-0186

BC-LI-0186
T9533-1g 1g Ask for price
Description: BC-LI-0186

BC-LI-0186
T9533-1mg 1mg Ask for price
Description: BC-LI-0186

BC-LI-0186
T9533-50mg 50mg Ask for price
Description: BC-LI-0186

BC-LI-0186
T9533-5mg 5mg Ask for price
Description: BC-LI-0186

BC 11 Hydrobromide
TRC-B129348-10MG 10 mg Ask for price

BC 11 Hydrobromide
TRC-B129348-50MG 50 mg Ask for price

BC 11 Hydrobromide
TRC-B129348-100MG 100 mg Ask for price

11H-Benz[bc]aceanthrylene
B183400 0.5mg
EUR 2388
Description: 202-94-8

MS BC POTATO MEDIUM
M516 10L
EUR 35.14

11H-Benz[bc]aceanthrylene
TRC-B183400-0.5MG 0.5 mg Ask for price

11H-Benz[bc]aceanthrylene
TRC-B183400-5MG 5 mg Ask for price

113-N16B
HY-153737 Get quote Ask for price
Description: 113-N16B is an ionizable cationic lipid used for the generation of lipid nanoparticles (LNPs). 113-N16B delivers mRNA preferentially to pulmonary endothelial cells.

SI-113
HY-117357 10 mg
EUR 119.05
Description: SI-113 is a SGK1 inhibitor, with an IC50 of 600 nM. SI113 induces autophagy[1][2].

SI-113
MBS5786438-10mg 10(mg
EUR 240

SI-113
MBS5786438-2mg 2(mg
EUR 165

SI-113
MBS5786438-5mg 5(mg
EUR 190

RTI-113
MBS6091088-5mg 5(mg
EUR 610

RTI-113
MBS6091088-5x5mg 5x5(mg
EUR 2600

FAUC-113
MBS5775136-5mg 5(mg
EUR 915

FAUC-113
MBS5775136-5x5mg 5x5(mg
EUR 3970

P-113
MBS5775645-50mg 50(mg
EUR 1110

P-113
MBS5775645-5x50mg 5x50mg
EUR 4850

A 113
MBS5779125-5mg 5(mg
EUR 915

A 113
MBS5779125-5x5mg 5x5(mg
EUR 3970

A 113
T29491-10mg 10mg Ask for price
Description: A 113

A 113
T29491-1g 1g Ask for price
Description: A 113

A 113
T29491-1mg 1mg Ask for price
Description: A 113

A 113
T29491-50mg 50mg Ask for price
Description: A 113

A 113
T29491-5mg 5mg Ask for price
Description: A 113

P-113
T25913-10mg 10mg Ask for price
Description: P-113

P-113
T25913-1g 1g Ask for price
Description: P-113

P-113
T25913-1mg 1mg Ask for price
Description: P-113

P-113
T25913-50mg 50mg Ask for price
Description: P-113

P-113
T25913-5mg 5mg Ask for price
Description: P-113

FAUC-113
T25407-10mg 10mg Ask for price
Description: FAUC-113

FAUC-113
T25407-1g 1g Ask for price
Description: FAUC-113

FAUC-113
T25407-1mg 1mg Ask for price
Description: FAUC-113

FAUC-113
T25407-50mg 50mg Ask for price
Description: FAUC-113

FAUC-113
T25407-5mg 5mg Ask for price
Description: FAUC-113

RTI-113
R701110 50mg
EUR 187
Description: 141807-57-0

SI-113
T9589-10mg 10mg Ask for price
Description: SI-113

SI-113
T9589-1g 1g Ask for price
Description: SI-113

SI-113
T9589-1mg 1mg Ask for price
Description: SI-113

SI-113
T9589-50mg 50mg Ask for price
Description: SI-113

SI-113
T9589-5mg 5mg Ask for price
Description: SI-113

RTI-113
TRC-R701110-50MG 50 mg Ask for price

RTI-113
TRC-R701110-5MG 5 mg Ask for price

Human CD46-BC, His-tag
71230 100 µg
EUR 320
Description: Human CD46-BC, also known as membrane co-factor protein, Genbank Accession No. BC_030594, a.a. 35-328 with C-terminal His-tag, expressed in a HEK293 cell expression system. MW = 36.6 kDa (precursor), 34.2 kDa (mature). Note: this protein is expressed with a 34 amino acid signal sequence that is cleaved after secretion and is heavily glycosylated, resulting in a protein that runs at a higher apparent MW.

Monkey CD46-BC, His-tag
71232 100 µg
EUR 320
Description: Cynomolgus monkey (Macaca fascicularis) CD46-BC, also known as membrane co-factor protein, a.a. 35-328 with C-terminal His-tag, expressed in a HEK293 cell expression system. MW = 36.5 kDa (precursor), 34.2 kDa (mature). Note: this protein is expressed with a 34 amino acid signal sequence that is cleaved after secretion and is heavily glycosylated, resulting in a protein that runs at a higher apparent MW.

11H-Benz[bc]aceanthrylene-d12
B183402 100mg
EUR 9200

MM-Separator 96 SBS BC
MDMG0007 1
EUR 1410

11H-Benz[bc]aceanthrylene-d12
TRC-B183402-100MG 100 mg Ask for price

In this overview, we present the state of the science of LID research at the local scale, considerations for scaling this research to catchments, recent advances and findings in scaling the effects of LID practices on water quality and quantity at catchment scales, and the use of models as novel tools for these scaling efforts.